Non-Current Assets

Accumulated Depreciation

Gilead Sciences Accumulated Depreciation increased by 3.3% to $2.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $2.54B to $2.78B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows a downward trend with a -16.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Parent metricPP&E (Net)

How to read this metric

A rising balance relative to gross assets suggests an aging infrastructure, potentially signaling a need for future capital expenditure to replace equipment.

Detailed definition

This is the cumulative amount of depreciation expense charged against the company's tangible assets since their acquisit...

Peer comparison

Commonly found in the balance sheet or notes for all companies with significant physical property, plant, and equipment.

Metric ID: ppe_accumulated_depreciation

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.50B$7.94B$8.38B$8.83B$9.25B$9.70B$10.12B$10.67B$11.27B$11.86B$12.44B$13.03B$13.63B$14.22B$2.47B$2.54B$2.62B$2.69B$2.70B$2.78B
QoQ Change+5.9%+5.6%+5.3%+4.8%+4.8%+4.3%+5.4%+5.6%+5.3%+4.8%+4.8%+4.6%+4.4%-82.6%+2.9%+3.1%+2.7%+0.1%+3.3%
YoY Change+23.5%+22.2%+20.8%+20.8%+21.7%+22.3%+22.9%+22.2%+21.0%+19.9%-80.1%-80.5%-80.8%-81.1%+9.1%+9.5%
% of PP&E (Net)150.0%157.6%163.7%168.0%174.6%181.3%184.9%194.7%203.3%212.9%233.9%244.9%254.9%263.8%45.6%46.9%48.0%49.0%48.1%49.4%
Share Change+7.5pp+6.1pp+4.4pp+6.6pp+6.7pp+3.5pp+9.8pp+8.7pp+9.6pp+21.0pp+11.0pp+10.0pp+8.9pp-218.2pp+1.3pp+1.1pp+1.0pp-0.9pp+1.3pp
Range$2.47B$14.22B
CAGR-18.8%
Avg YoY Growth-5.4%
Median YoY Growth+20.8%
Current Streak5 quarters growth

Frequently Asked Questions

What is Gilead Sciences's accumulated depreciation?
Gilead Sciences (GILD) reported accumulated depreciation of $2.78B in Q1 2026.
How has Gilead Sciences's accumulated depreciation changed year-over-year?
Gilead Sciences's accumulated depreciation increased by 9.5% year-over-year, from $2.54B to $2.78B.
What is the long-term trend for Gilead Sciences's accumulated depreciation?
Over 5 years (2020 to 2025), Gilead Sciences's accumulated depreciation has grown at a -16.5% compound annual growth rate (CAGR), from $6.66B to $2.70B.
What does accumulated depreciation mean?
The total amount of depreciation recorded against physical assets over time.